CME · NASDAQ
CME Group (CME) Stock Price & Fundamentals
CME Group (CME) closed at $705.25 on Oct 9, 2026, up 0.82% from the previous close of $699.54.
Share price, past year
1Y +17.87%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $705.25 |
| Sep 30, 2026 | $720.84 |
| Aug 31, 2026 | $667.41 |
| Jul 31, 2026 | $638.13 |
| Jun 30, 2026 | $637.70 |
| May 29, 2026 | $653.36 |
| Apr 30, 2026 | $688.63 |
| Mar 31, 2026 | $638.53 |
| Feb 27, 2026 | $641.49 |
| Jan 30, 2026 | $640.14 |
| Dec 31, 2025 | $606.03 |
| Nov 28, 2025 | $595.61 |
| Oct 31, 2025 | $586.31 |
Key statistics
- Market cap
- —
- P/E (TTM)
- 59.8
- EPS (TTM)
- $11.79
- Revenue (TTM)
- $6.77B
- Net income (TTM)
- —
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $576.18 – $720.84
Financials
CME Group reported revenue of $6.52B for fiscal 2025, up 6.37% from fiscal 2024.
CME Group earned net income of $4.07B in fiscal 2025, a net margin of 62.5%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $6.52B | +6.4% | $4.07B | 62.5% | $11.16 | $4.19B |
| FY2024ended Dec 31, 2024 | $6.13B | +9.9% | $3.53B | 57.5% | $9.67 | $3.60B |
| FY2023ended Dec 31, 2023 | $5.58B | +11.2% | $3.23B | 57.8% | $8.86 | $3.38B |
| FY2022ended Dec 31, 2022 | $5.02B | +7.0% | $2.69B | 53.6% | $7.40 | $2.97B |
| FY2021ended Dec 31, 2021 | $4.69B | −4.0% | $2.64B | 56.2% | $7.29 | $2.28B |
| FY2020ended Dec 31, 2020 | $4.88B | +0.3% | $2.11B | 43.1% | $5.87 | $2.52B |
| FY2019ended Dec 31, 2019 | $4.87B | +13.0% | $2.12B | 43.5% | $5.91 | $2.43B |
| FY2018ended Dec 31, 2018 | $4.31B | +18.2% | $1.96B | 45.5% | $5.71 | $2.32B |
| FY2017ended Dec 31, 2017 | $3.64B | +1.4% | $4.06B | 111.5% | $11.94 | $1.67B |
| FY2016ended Dec 31, 2016 | $3.60B | — | $1.53B | 42.7% | $4.53 | $1.64B |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.71B | $1.04B | $2.88 |
| Q1 FY2026ended Mar 31, 2026 | $1.88B | — | $3.18 |
| Q4 FY2025ended Dec 31, 2025 | $1.65B | — | $3.24 |
| Q3 FY2025ended Sep 30, 2025 | $1.54B | — | $2.49 |
| Q2 FY2025ended Jun 30, 2025 | $1.69B | $1.03B | $2.81 |
| Q1 FY2025ended Mar 31, 2025 | $1.64B | — | $2.62 |
| Q4 FY2024ended Dec 31, 2024 | $1.53B | — | $2.40 |
| Q3 FY2024ended Sep 30, 2024 | $1.58B | — | $2.50 |
Company profile
- Name
- CME Group Inc.
- Ticker
- CME
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Security & Commodity Brokers, Dealers, Exchanges & Services
- Headquarters
- 20 S. Wacker Dr., Chicago, IL 60606
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001156375
Recent SEC filings
- Sep 25, 2026
- Sep 9, 2026
- Aug 11, 2026
- Jul 24, 2026
- Jul 22, 2026
- Jun 17, 2026
- Jun 10, 2026
- May 19, 2026
Frequently asked questions
What is CME Group's stock price?
CME Group (CME) closed at $705.25 on Oct 9, 2026, up 0.82% from the previous close of $699.54.
How much revenue does CME Group make?
CME Group reported revenue of $6.52B for fiscal 2025, up 6.37% from fiscal 2024.
What is CME's P/E ratio?
CME Group's price-to-earnings ratio is 59.8, based on trailing twelve-month diluted EPS of $11.79.
Does CME Group pay a dividend?
Yes. CME Group declared $5.00 per share in dividends for fiscal 2025.
Sources and methodology
Fundamentals come from CME Group Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures